Which Statement Is True When Someone With a Medicare Advantage Plan Enrolls in a Medicare Supplement Plan

The statement that is true is this: enrolling in a Medicare supplement (Medigap) plan does not cancel or replace your Medicare Advantage (MA) plan automatically, but the two cannot legally work together, and in most states a Medigap insurer may refuse to sell you a policy or will require you to disenroll from MA first. In practice, the enrollment is either blocked, delayed until you drop MA, or completed in a way that leaves the Medigap policy unable to pay benefits while MA is active.

This answer sounds paradoxical, so it deserves a mechanism-level unpacking. The confusion arises because MA and Medigap occupy two different legal layers of the Medicare program. Understanding why they are mutually exclusive requires knowing what each product actually insures, who regulates the sale, and what happens to your existing coverage at the moment of application.

The two-layer legal architecture

Original Medicare is a federal fee-for-service program with two parts: Part A for hospital care and Part B for outpatient and physician services. Medigap policies are state-regulated private insurance that pays some of Original Medicare's cost-sharing, such as the Part A deductible, the Part B coinsurance, and in some plans the Part B deductible. Critically, Medigap benefits are defined as payments toward Original Medicare's cost-sharing obligations. They are not general health insurance.

Medicare Advantage is a different pathway entirely. Under Part C of Medicare, a private insurer receives a capitated payment from the federal government and delivers all Part A and Part B benefits itself, usually through a network and often with extra benefits such as dental or vision. When you enroll in MA, you are still in Medicare, but your claims are processed by the plan rather than by Original Medicare.

The mechanism that makes the two incompatible is the claims-processing layer. A Medigap policy's benefit triggers when Original Medicare adjudicates a claim and leaves a patient responsibility. If you are in an MA plan, Original Medicare does not adjudicate your claims; the MA plan does. The Medigap policy therefore has no adjudicated cost-sharing to pay. It is not that Medigap pays zero by accident. It pays zero because the event that activates its benefits never occurs.

Plain language: Medigap is a subsidy attached to Original Medicare's bill, and when MA pays the bill instead, there is no bill for Medigap to subsidize.

Why insurers screen for MA status at application

Federal law permits Medigap insurers to sell policies to people with MA only if the insurer confirms the applicant will disenroll or has disenrolled. The practical consequence is that most applications include an attestation about current MA enrollment, and carriers routinely verify enrollment status through federal data sources before issuing a policy.

There is also a structural gate: Medigap guaranteed-issue rights are tied to specific windows. During the six-month Medigap open enrollment period that begins the month you are 65 or older and enrolled in Part B, insurers must sell you any Medigap policy regardless of health, but this protection applies to people in Original Medicare. If you are in MA at that time, the guaranteed-issue right generally does not attach to a Medigap purchase while MA remains in force.

The counterintuitive professional caveat is that some agents will describe an MA-to-Medigap transition as simply "adding" coverage. It is not additive. The correct sequence is a disenrollment from MA, effective on a defined date, followed by or coordinated with a Medigap effective date. If the dates are misaligned, you can end up with a gap with no coverage or a Medigap policy that is legally in force but functionally inert for the period MA remains active.

Quantified context: what the incompatibility costs

The dollar exposure of getting this wrong is concrete. In Original Medicare, the Part A deductible for a hospital stay is a per-benefit-period amount that changes annually, and Part B coinsurance is generally 20 percent of the Medicare-approved amount with no annual out-of-pocket cap. A Medigap Plan G, for example, pays that Part B coinsurance and the Part A deductible, leaving the Part B deductible as the main residual cost. Without Medigap for a hospital episode, a beneficiary can face the full Part A deductible plus 20 percent coinsurance on physician services, and repeated hospitalizations can compound the exposure.

MA plans, by contrast, have an annual in-network maximum out-of-pocket limit, which for many plans falls in the range of several thousand dollars, though the exact figure varies by plan and year. The trade-off is not simply "Medigap is more generous." MA often has lower premiums and built-in drug coverage, while Medigap typically has higher premiums and requires a separate Part D plan.

The cost of a coverage gap is driven by the combination of a hospital deductible and coinsurance, not by a single flat penalty. For a beneficiary who transitions from MA to Medigap and experiences a date misalignment, the exposure is the encounter cost incurred during the gap, which can exceed the annual MA out-of-pocket cap in a single hospitalization. This is why sequencing is not an administrative detail; it is the risk management step.

Timeline mechanics of a transition

The sequence of a lawful MA-to-Medigap transition has a distinct time course, and the order of operations matters more than the calendar dates themselves.

The key structural point is that the Medigap effective date must not precede the MA termination date. If it does, the policy exists but cannot pay, and you may have paid premiums for coverage that could not function.

Edge cases and trial rights

There is one federally recognized path that allows a Medigap purchase after MA without medical underwriting in many circumstances: the trial right. If you first enrolled in MA when you turned 65 and leave it within the first 12 months, you may have a guaranteed-issue right to buy certain Medigap policies. This right is narrow and time-limited, and it does not apply to people who had Original Medicare and Medigap before joining MA.

A second edge case involves people who are under 65 and eligible for Medicare due to disability. Federal guaranteed-issue protections for this group are limited, and state rules vary widely. Some states require Medigap insurers to sell to disabled beneficiaries; others do not. This is a state-law question, not a federal one, and it is a common source of incorrect blanket statements.

A third edge case is the employer-group MA plan, such as an MA plan sponsored through a former employer. Leaving such a plan may interact with retiree health obligations, and the disenrollment mechanics can differ from individual MA plans.

Misconceptions that survive contact with the rules

The most persistent misconception is that you can hold both and simply "use Medigap when MA denies a claim." Medigap does not function as a secondary payer behind MA. It pays Original Medicare cost-sharing, and MA claims are not Original Medicare claims. There is no coordination-of-benefits pathway that turns Medigap into MA supplemental coverage.

A second misconception is that dropping MA automatically triggers a Medigap guaranteed-issue right. It does not. Outside the initial Medigap open enrollment period and the narrow trial right, medical underwriting applies, and an insurer can decline or rate up the policy based on health history.

A third misconception is that the Medigap open enrollment period is available whenever you want it. It is a one-time window tied to age and Part B enrollment, not a recurring annual right.

Practical actions and thresholds

Use these steps to sequence a transition correctly. Each threshold below is a decision point, and the thresholds should be reconciled rather than treated as independent.

Confirm your Medigap open enrollment window status. If you are within six months of turning 65 and enrolling in Part B, you have guaranteed-issue rights; if you are beyond it, expect underwriting. Verify whether you qualify for the 12-month MA trial right. This applies only if you first enrolled in MA at 65, and it expires at the 12-month mark. Set the MA disenrollment effective date first, then set the Medigap effective date on or after it. Never let Medigap start before MA ends. Arrange a separate Part D drug plan, because Medigap policies sold today do not include prescription drug coverage. Keep written confirmation from both the MA plan and the Medigap insurer showing the termination and effective dates. Red flag: an agent who says you can keep MA and "add" Medigap. That arrangement cannot pay benefits and may violate enrollment attestation rules.

The reconciliation point is this: the guaranteed-issue window, the trial right, and the effective-date rule are three separate thresholds. Meeting one does not satisfy the others. A person inside the open enrollment window still must sequence the dates correctly, and a person using the trial right still must complete disenrollment.

Limitations and what this cannot tell you

This explanation covers the federal architecture and the general state-level pattern, but Medigap regulation is partly state-specific. A handful of states have different rules on guaranteed issue, underwriting, and plan availability, and those differences can change the answer for a specific person. Plan availability and premiums also vary by location and year.

Nothing here constitutes a coverage determination. The correct answer for any individual depends on their enrollment history, their state, their health status, and the specific plans involved.

This article is general educational information about how Medicare Advantage and Medigap interact. It is not a diagnosis, treatment plan, legal opinion, or insurance recommendation, and it does not promise any coverage outcome. Consult a licensed insurance professional or your State Health Insurance Assistance Program for guidance on your specific situation, and contact local emergency services if you face an urgent health or safety issue.